AlphaCrest Capital Management’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,523
Closed -$359K 1299
2022
Q2
$359K Sell
6,523
-2,883
-31% -$186K 0.02% 1048
2022
Q1
$644K Buy
9,406
+1,278
+16% +$91K 0.04% 770
2021
Q4
$643K Buy
+8,128
New +$680K 0.02% 1003
2021
Q2
Sell
-5,811
Closed -$438K 1250
2021
Q1
$438K Buy
5,811
+1,136
+24% +$83.3K 0.02% 861
2020
Q4
$308K Buy
+4,675
New +$273K 0.03% 910
2020
Q3
Sell
-4,285
Closed -$206K 1121
2020
Q2
$206K Buy
+4,285
New +$189K 0.03% 832
2019
Q1
Sell
-23,879
Closed -$859K 847
2018
Q4
$859K Buy
+23,879
New +$1.11M 0.26% 91

Other funds holding ENOV

AlphaCrest Capital Management's ENOV Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of Enovis (ENOV) in Q3 2022, closing a stake of 6,523 shares — an estimated $359K sold.

AlphaCrest Capital Management first reported a position in ENOV in Q4 2018 and held it in 7 quarters. The position peaked at $859K in Q4 2018. 242 funds tracked by Wall St. Rank hold ENOV as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining Enovis position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 6,523 Enovis shares in Q3 2022, an estimated $359K.
  • AlphaCrest Capital Management first reported a position in Enovis in Q4 2018 and held it in 7 quarters.
  • AlphaCrest Capital Management's Enovis position peaked at $859K in Q4 2018.
  • 242 funds tracked by Wall St. Rank held Enovis as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.